Skip to main content
CivicGate

HR 9703
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Improving Access to Transfusion Care for Hospice Patients Act of 2026

To require the Center for Medicare and Medicaid Innovation to test allowing blood transfusions to be paid separately from the Medicare hospice all-inclusive per diem payment.

Introduced Jul 15, 2026

Latest action (Jul 15, 2026) Referred to the House Committee on Ways and Means.

Policy area
Issues
Healthcare

Summary

  • Directs the Center for Medicare and Medicaid Innovation (CMI) to establish and implement a test model within 1 year of enactment.
  • Under the model, blood transfusions furnished to Medicare hospice patients would be paid separately from the hospice all-inclusive per diem payment.
  • The separate payment amount would be the amount that would otherwise apply under Medicare if the transfusion were not furnished as part of hospice care.
  • Adds the model to the models that must be selected under Section 1115A(b)(2)(A) of the Social Security Act.
  • Requires the evaluation to compare model participants with similar patients outside the model on metrics including chemotherapy in the last 14 days of life, hospital and ICU use in the last 30 days of life, days of hospice care before death, and transfusion frequency and counts.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Money behind the sponsor

Top reported contributors to Debbie Dingell’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • UNIVERSITY OF MICHIGAN $24,944
  • THE WONDERFUL COMPANY $13,200
  • Employer not reported $9,900
  • ANN ARBOR EDUCATIONAL FOUNDATION $6,600
  • DAKKOTA INTREGRATED SYSTEMS LLC $6,600

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Debbie Dingell → · Outside spending →

Actions (2)

  1. Jul 15, 2026 Referred to the House Committee on Ways and Means. · house
  2. Jul 15, 2026 Introduced in House

Full text

IN THE HOUSE OF REPRESENTATIVES

July 15, 2026

Mrs. Dingell introduced the following bill; which was referred to the Committee on Ways and Means

A BILL

To require the Center for Medicare and Medicaid Innovation to test allowing blood transfusions to be paid separately from the Medicare hospice all-inclusive per diem payment.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Improving Access to Transfusion Care for Hospice Patients Act of 2026”.

SEC. 2. CENTER FOR MEDICARE AND MEDICAID INNOVATION TESTING OF ALLOWING BLOOD TRANSFUSIONS TO BE PAID SEPARATELY FROM THE MEDICARE HOSPICE ALL-INCLUSIVE PER DIEM PAYMENT.

Section 1115A of the Social Security Act (42 U.S.C. 1315a) is amended—

(1) in subsection (b)(2)(A), by adding at the end the following new sentence: “The models selected under this subparagraph shall include the testing of the model described in subsection (h).”; and

(2) by adding at the end the following new subsection:

“(h) Testing of Allowing Blood Transfusions To Be Paid Separately From the Medicare Hospice All-Inclusive Per Diem Payment.—

“(1) In general.—Not later than 1 year after the date of enactment of this subsection, the CMI shall establish and implement a model under which blood transfusions furnished to an individual receiving hospice care are paid separately from the hospice all-inclusive per diem payment under section 1814(i). The separate payment amount for such blood transfusion shall be the amount that would otherwise apply under title XVIII if the transfusion was not furnished as part of hospice care.

“(2) Requirements for evaluation.—In conducting any evaluation of the model described in paragraph (1) pursuant to subsection (b)(4), the CMI shall ensure it compares participants under the model with similar patients outside of the model with respect to the following metrics:

“(A) The number of chemotherapy services furnished in the last 14 days of life.

“(B) Hospital utilization in the last 30 days of life, including emergency department visits, in-patient and observation status stays (including the length of the stays), and intensive care unit (ICU) days.

“(C) How many days receiving hospice care before the end of life.

“(D) The number of patients receiving hospice care who received a transfusion compared to patients with similar diagnoses not receiving hospice care.

“(E) The average frequency of transfusion for patients receiving hospice care compared to patients not receiving hospice care.

“(F) The number of transfusions for patients receiving hospice care compared to patients not receiving hospice care.

“(G) Other areas determined appropriate by the CMI.”. <all>

Text versions (1)

  • Introduced in House · Jul 15, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Comments

Comments

Loading comments…